HCP (HCP) Downgraded by JPMorgan Chase & Co.

JPMorgan Chase & Co. cut shares of HCP (NYSE:HCP) from an overweight rating to a neutral rating in a report published on Friday morning, Marketbeat Ratings reports.

Several other equities research analysts have also commented on HCP. ValuEngine lowered shares of HCP from a sell rating to a strong sell rating in a report on Wednesday, June 13th. Cantor Fitzgerald upgraded shares of HCP from a neutral rating to an overweight rating and boosted their price target for the company from $28.00 to $29.00 in a report on Thursday, September 27th. Robert W. Baird boosted their price target on shares of HCP from $24.00 to $26.00 and gave the company a neutral rating in a report on Thursday, August 9th. Morgan Stanley reduced their price target on shares of HCP from $28.00 to $23.50 and set an equal weight rating for the company in a report on Thursday, June 14th. Finally, Zacks Investment Research lowered shares of HCP from a hold rating to a sell rating in a report on Tuesday, July 31st. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the company. HCP presently has a consensus rating of Hold and a consensus price target of $26.54.

NYSE:HCP opened at $25.20 on Friday. HCP has a one year low of $21.48 and a one year high of $27.62. The company has a debt-to-equity ratio of 1.37, a current ratio of 0.51 and a quick ratio of 0.51. The stock has a market capitalization of $12.37 billion, a PE ratio of 12.92, a price-to-earnings-growth ratio of 6.61 and a beta of 0.28.

HCP (NYSE:HCP) last posted its quarterly earnings results on Thursday, August 2nd. The real estate investment trust reported $0.19 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.27). HCP had a net margin of 3.39% and a return on equity of 1.12%. The business had revenue of $469.60 million during the quarter, compared to the consensus estimate of $463.94 million. During the same quarter in the prior year, the firm posted $0.48 EPS. The company’s revenue for the quarter was up 2.3% compared to the same quarter last year. Research analysts forecast that HCP will post 1.82 earnings per share for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Stephens Inc. AR increased its stake in HCP by 5.1% during the 2nd quarter. Stephens Inc. AR now owns 40,944 shares of the real estate investment trust’s stock valued at $1,057,000 after purchasing an additional 1,993 shares in the last quarter. Advisor Partners LLC increased its stake in HCP by 20.7% during the 2nd quarter. Advisor Partners LLC now owns 11,864 shares of the real estate investment trust’s stock valued at $306,000 after purchasing an additional 2,038 shares in the last quarter. Amalgamated Bank increased its stake in HCP by 3.6% during the 2nd quarter. Amalgamated Bank now owns 60,479 shares of the real estate investment trust’s stock valued at $1,562,000 after purchasing an additional 2,084 shares in the last quarter. Spearhead Capital Advisors LLC increased its stake in HCP by 1.8% during the 2nd quarter. Spearhead Capital Advisors LLC now owns 137,553 shares of the real estate investment trust’s stock valued at $3,552,000 after purchasing an additional 2,398 shares in the last quarter. Finally, First Midwest Bank Trust Division increased its stake in HCP by 9.3% during the 2nd quarter. First Midwest Bank Trust Division now owns 28,695 shares of the real estate investment trust’s stock valued at $741,000 after purchasing an additional 2,433 shares in the last quarter. Hedge funds and other institutional investors own 88.30% of the company’s stock.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: Book Value Per Share – BVPS

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply